Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology?

by Roy Fleischmann, Vipul Jairath, Eduardo Mysler, Dave Nicholls, Paul Declerck
Published 2020-01-01

Perception toward Biosimilars and Nonmedical Switching: A Cross-sectional Survey among Arab Rheumatologists

by Mohammed A. Omair, Humaid Al Wahshi, Jamal Al Saleh, Farida Al Balushi, Mostafa Zayed, Maha A. Omair, Eduardo Mysler
Published 2020-08-01

Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b...

by Boulos Haraoui, Janet Pope, Edward C Keystone, Eduardo Mysler, Tatjana Lukic, Harry Shi, Stanley B Cohen, Rebecca Germino, Lori Stockert, Annette Diehl, Sujatha Menon, Shixue Liu
Published 2021-08-01